Yahoo! JAPAN

2024/4/8 -Kelun-Biotech has established a complete innovative drug clinical research and operation platform under the protection of its electronic management system. The ...

2023/12/7 -Kelun-Biotech Announces the Latest Clinical Study Results of SKB264 (MK-2870) for the Treatment of TNBC at 2023 SABCS. Kelun-Biotech presented updated ...

2024/4/10 -Merck and Kelun-Biotech's antibody-drug conjugate achieved a 22% objective response rate and 80.5% disease control rate in heavily pretreated patients with ...

2023/12/7 -In summary, SKB264 exerts its anti-tumor effect in three ways. Firstly, the pH-sensitive linker can cleave and release T030 in the acidic tumor microenvironment ...

2023/12/29 -... 非经营性-2020-0229 | 网站建设：中企动力成都 | 网站管理入口. Copyright @ 2012 kelun.com，All Rights Reserved | 友情链接：OKMAN官方网站. <. > 更多 · 抗击新冠.

2024/3/18 -In May 2022 Merck paid Kelun $47m for undisclosed ADC projects later revealed to include saci-tirumo. The tally of disclosed phase 3 trials now comprises four ...

2024/1/11 -As one of the pioneers in the antibody-drug conjugates (ADC) development company, Kelun-Biotech has established world leading ADC platform "OptiDC™", as well as ...

2024/1/4 -Kelun Lu studies school reputation and parental satisfaction, primarily focusing on using the Natural Language Processing (NLP) and causal inference to ...

2023/12/1 -Kelun Lifesciences PVT LTD. 2959 likes · 10 talking about this. A pharmaceutical manufacturing company located in BOI Pallakale.

2024/4/8 -Kelun-Biotech (6990.HK) is a holding subsidiary of Kelun Pharmaceutical (002422.SZ), which focuses on the R&D, manufacturing, commercialization and global ...